Cargando…

Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma

Merkel cell carcinoma (MCC) is an aggressive, polyomavirus-associated cancer with limited therapeutic options for metastatic disease. Cytotoxic chemotherapy is associated with high response rates, but responses are seldom durable and toxicity is considerable. Here, we report our experience with pall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyer, Jayasri G, Parvathaneni, Upendra, Gooley, Ted, Miller, Natalie J, Markowitz, Elan, Blom, Astrid, Lewis, Christopher W, Doumani, Ryan F, Parvathaneni, Kaushik, Anderson, Austin, Bestick, Amy, Liao, Jay, Kane, Gabrielle, Bhatia, Shailender, Paulson, Kelly, Nghiem, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559027/ https://www.ncbi.nlm.nih.gov/pubmed/25908228 http://dx.doi.org/10.1002/cam4.458

Ejemplares similares

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma
por: Iyer, Jayasri G., et al.
Publicado: (2016)

Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 Patients
por: Tarabadkar, Erica S., et al.
Publicado: (2018)

How we treat Merkel cell carcinoma: within and beyond current guidelines
por: Park, Song Y, et al.
Publicado: (2021)

Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
por: Cook, Maclean M., et al.
Publicado: (2020)

Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck
por: Takagishi, Seesha R., et al.
Publicado: (2016)

Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec
por: Singh, Neha, et al.
Publicado: (2023)

Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival
por: Paulson, Kelly G., et al.
Publicado: (2012)

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review
por: Akaike, Tomoko, et al.
Publicado: (2022)

Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance
por: Lewis, Christopher W., et al.
Publicado: (2019)

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
por: Bhatia, Shailender, et al.
Publicado: (2022)

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
por: Carter, Joseph J., et al.
Publicado: (2009)

Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma
por: Koba, Shinichi, et al.
Publicado: (2012)

Correction: Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma
por: Koba, Shinichi, et al.
Publicado: (2012)

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
por: D'Angelo, Sandra P, et al.
Publicado: (2020)

Travel burden associated with rare cancers: The example of Merkel cell carcinoma
por: Jain, Rahul, et al.
Publicado: (2019)

Technical Advances and Pitfalls in Head and Neck Radiotherapy
por: Parvathaneni, Upendra, et al.
Publicado: (2012)

In Regard to Barker
por: Goff, Peter H., et al.
Publicado: (2021)

Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
por: Goh, Gerald, et al.
Publicado: (2015)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
por: Miller, Natalie J., et al.
Publicado: (2018)

A Combined Neutron and Proton Regimen for Advanced Salivary Tumors: Early Clinical Experience
por: Aljabab, Saif, et al.
Publicado: (2021)

Immunotherapy for Merkel cell carcinoma: a turning point in patient care
por: Chan, Isaac S., et al.
Publicado: (2018)

Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes
por: Gensheimer, Michael F, et al.
Publicado: (2014)

Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique
por: Gensheimer, Michael F., et al.
Publicado: (2016)

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
por: Nghiem, Paul, et al.
Publicado: (2021)

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study
por: D'Angelo, Sandra P, et al.
Publicado: (2021)

Validation of the [Formula: see text] photon convolution‐superposition algorithm applied to fast neutron beams
por: Kalet, Alan M., et al.
Publicado: (2013)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
por: Kaufman, Howard L., et al.
Publicado: (2018)

Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution
por: Williams, Vonetta M., et al.
Publicado: (2021)

Comparisons of 3-Dimensional Conformal and Intensity-Modulated Neutron Therapy for Head and Neck Cancers
por: Viscariello, Natalie, et al.
Publicado: (2021)

Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma
por: Afanasiev, Olga K., et al.
Publicado: (2013)

Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management
por: Breneman, Alyssa, et al.
Publicado: (2021)

Merkel cell carcinoma in lymph nodes with and without primary origin
por: Fennig, Shlomit, et al.
Publicado: (2022)

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
por: Ritter, Cathrin, et al.
Publicado: (2016)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
por: D’Angelo, Sandra P., et al.
Publicado: (2019)

Lady Windermere Syndrome: Unravelling an Older Lady's Nightmare
por: Parvathaneni, Aparna, et al.
Publicado: (2023)

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma
por: Tachiki, Lisa May Ling, et al.
Publicado: (2023)

Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
por: Park, Song Y., et al.
Publicado: (2020)

Self-Learning Network-based segmentation for real-time brain M.R. images through HARIS
por: Naga Srinivasu, Parvathaneni, et al.
Publicado: (2021)

Does a new polyomavirus contribute to Merkel cell carcinoma?
por: Garneski, Kelly M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_06vpng4qv95eu43l72ordkrqfq